CompletedPhase 4NCT01821911
The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use
Studying Rabies
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Center for Disease Control and Prevention
- Principal Investigator
- Nianmin ShiBeijing Chaoyang District Centers for Disease Control and Prevention
- Intervention
- Zagreb2-1-1(biological)
- Enrollment
- 10500 target
- Eligibility
- All sexes
- Timeline
- 2012 – 2014
Study locations (3)
- Guangdong Centers for Disease Control and Prevention, Zhaoqing, Guangdong, China
- Wuhan Centers for Disease Control and Prevention, Wuhan, Hubei, China
- Beijing Chaoyang District Centers for Disease Control and Prevention, Beijing, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01821911 on ClinicalTrials.govOther trials for Rabies
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT07500207A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)Changchun BCHT Biotechnology Co.
- ACTIVE NOT RECRUITINGPHASE3NCT07275645A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 YearsAb&B Bio-tech Co., Ltd.JS
- ENROLLING BY INVITATIONPHASE1NCT07338786A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)Changchun BCHT Biotechnology Co.
- RECRUITINGPHASE1NCT07021703A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-driedNingbo Rongan Biological Pharmaceutical Co., Ltd.
- RECRUITINGPHASE1NCT06998004A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy AdultsAstriVax Therapeutics
- ENROLLING BY INVITATIONPHASE3NCT05545371Prevention of Rabies With Four Doses of Rabies VaccineChangchun Zhuoyi Biological Co., Ltd
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04270838A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGUniversity of Oxford